/
We are a leading global provider of integrated, temperature-controlled supply chain solutions for the life sciences, with a strong focus on supporting the rapidly growing cell and gene therapy ( CGT ) market. Our solutions are purpose-built to support a broad range of global life sciences markets, including biopharmaceutical and pharmaceutical companies, the animal health markets, reproductive …
The business is unprofitable at the operating level (-20.89% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 12.4% YoY with margins expanding 56.7pp.
Negative free cash flow of -$25M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$183M
▲ +12.4% YoY
Net Income (TTM)
$80M
▲ +168.2% YoY
Op. Margin
-21.44%
▲ +56.7pp YoY
ROIC
-4.21%
▲ +8.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$24M
▲ +25.5% YoY
Op. Cash Flow (TTM)
-$503K
▲ +47.4% YoY
Net Debt
-$174M
Net Cash Position
Cash & Equiv.
$404M
5Y CAGR: +17.5%
Continue Research